Potential of superparamagnetic iron oxide in the differential diagnosis of metastasis and inflammation in bone marrow: Experimental study

Investigative Radiology

Volumn 40, Issue 10, 2005, Pages 676-681

  Tsuda, Natsuko ^a   Tsuji, Takashi ^a   Kato, Naoki ^a   Fukuda, Yuko ^b   Ando, Kumiko ^b   Ishikura, Reiichi ^b   Nakao, Norio ^b  

^a Nihon Schering   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Contrast media; Ferucarbotran; MRI; Rabbits

Indexed keywords

CONTRAST MEDIUM; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE METASTASIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; INFLAMMATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT;

EID: 25644456183     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000178435.04152.78     Document Type: Article

References (34)

1. Mundy GR. Mechanisms of bone metastasis. Cancer. 1997;80:1546-1556.
2. Rosenthal DI. Radiographic diagnosis of bone metastases. Cancer. 1997;80:1595-1607.
3. Söderlund V. Radiological diagnosis of skeletal metastases. Eur Radiol. 1996;6:587-595.
4. Frank JA, Ling A, Patronas NJ, et al. Detection of malignant bone tumors: MR imaging vs scintigraphy. AJR Am J Roentgenol. 1990;155: 1043-1048.
5. Yuh WTC, Zachar CK, Barloon TJ, et al. Vertebral compression fractures: distinction between benign and malignant cases with MR imaging. Radiology. 1989;172:215-218.
6. 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol. 1997;169:1655-1661.
7. Iizuka M, Nagai K, Tamada T, et al. Fundamental study of the detection of metastatic bone tumors with whole-body MR imaging. Nippon Acta Radiol. 1999;59:470-472.
8. Tamada T, Nagai K, Iizuka M, et al. Comparison of whole-body MR imaging and bone scintigraphy in the detection of bone metastases from breast cancer. Nippon Acta Radiol. 2000;60:249-254.
9. Baker LL, Goodman SB, Perkash I, et al. Benign versus pathologic compression fractures of vertebral bodies: assessment with conventional spin-echo, chemical-shift, and STIR MR imaging. Radiology. 1990;174:495-502.
10. Kickuth R, Laufer U, Pannek J, et al. Magnetic resonance imaging of bone marrow metastasis with fluid-fluid levels from small cell neuroendocrine carcinoma of the urinary bladder. Magn Reson Imaging. 2002; 20:691-694.
11. Park SW, Lee JH, Ehara S, et al. Single shot fast spin echo diffusion-weighted MR imaging of the spine; is it useful in differentiating malignant metastatic tumor infiltration from benign fracture edema? Clin Imaging. 2004;28:102-108.
12. 59Fe] AMI-25 in rats. Jpn Pharmacol Ther. 1994;22:869-881.
13. del Frate C, Bazzocchi M, Mortele KJ, et al. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. Radiology. 2002;225:766-772.
14. Kim JH, Kim MJ, Suh SH, et al. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: Utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging. 2002;15:573-583.
15. Alger JR, Harreld JH, Chen S, et al. Time-to-echo optimization for spin echo magnetic resonance imaging of liver metastasis using superparamagnetic iron oxide particles. J Magn Reson Imaging. 2001;14:586-594.
16. Lucidarme O, Baleston F, Cadi M, et al. Non-invasive detection of liver fibrosis: is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? Eur Radiol. 2003;13:467-474.
17. Yamashita Y, Tamamoto H, Hirai A, et al. MR imaging enhancement with superparamagnetic iron oxide in chronic liver disease: influence of liver dysfunction and parenchymal pathology. Abdom Imaging. 1996;21:318-323.
18. Mikami M. Application of diffusion-weighted MR imaging to the diagnosis of bone metastasis: a fundamental study using rabbit bone tumor model. Nippon Acta Radiol. 2004;64:107-113.
19. Taupitz M, Wagner S, Schnorr J, et al. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest Radiol. 2004;39:394-405.
20. Raynal I, Prigent P, Peyramaure S, et al. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles. Invest Radiol. 2004;39:56-63.
21. Bush CH, Mladinich CRJ, Montgomery WJ. Evaluation of an ultrasmall superparamagnetic iron oxide in MRI in a bone tumor model in rabbits. J Magn Reson Imaging. 1997;7:579-584.
22. Seneterre E, Weissleder R, Jaramillo D, et al. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology. 1991;179: 529-533.
23. Bellin MF, Lebleu L, Meric JB. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom imaging. 2003;28:155-163.
24. Rety F, Clement O, Siauve N, et al. MR lymphography using iron oxide nanoparticles in rats: pharmacokinetics in the lymphatic system after intravenous injection. J Magn Reson Imaging. 2000;12:734-739.
25. Daldrup-Link HE, Rudelius M, Oostendorp RAJ, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology. 2003;228:3:760-767.
26. Knollmann FD, Böck JC, Rautenberg K, et al. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography: preliminary results of an animal study original investigation. Invest Radiol. 1998;33:637-643.
27. Miyake T, Kimura I, Ito Y. A semi-quantitative method for the formation of tumor nodules in rabbit lung: experiments with VX2 carcinoma. Oncology. 1971;25:481-486.
28. Rous P, Beard JM. The progression to carcinoma of virus-induced rabbit papilloma (Shope). J Exp Med. 1935;62:523-548.
29. Miao Y, Ni Y, Yu J, et al. Evaluation of radiofrequency ablation as an alternative for the treatment of brain tumor in rabbits. J Neurooncol. 2002;56:119-126.
30. Lin YC, Chen JH, Han KW, et al. Ablation of liver tumor by injection of hypertonic saline. AJR Am J Roentgenol. 2005;184:212-219.
31. Saginoya T, Yamaguchi K, Nakano M. Experimental study of differentiation between tumor and inflammation using MR imaging: correlation between VX2 rumors and croton oil induced inflammation in the rabbit's femoral muscle. Nippon Acta Radiol. 1994;54:592-604.
32. Galea I, Palin K, Newman TA, et al. Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain. Glia. 2005;49:375-384.
33. Smythies LE, Sellers M, Clements RH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest. 2005;115:66-75.
34. Hudson G, Shortland JR. Bone marrow macrophages. In the reticuloendothelial system-a comprehensive treatise. Morphology. 1980;1:329-360.